ArticleFrontiers in medicine2025
A patient with acute pulmonary embolism caused by hyaluronic acid injection underwent nursing care of extracorporeal membrane oxygenation support therapy: a case report.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article summarizes the nursing management of a patient who developed acute pulmonary embolism with concomitant cardiopulmonary arrest following intravaginal hyaluronic acid injection, requiring extracorporeal membrane oxygenation (ECMO) support. The main measures are rapid activation of the treatment plan to improve the efficiency of treatment; teamwork and safe transfer; early implementation of target temperature management to promote neurological prognosis; implementation of individualized anticoagulation strategies and infection control strategies; and autologous blood transfusion techniques to reduce blood loss during ECMO withdrawal. After 9 days of active treatment and refined care, the patient's condition was stable, and she was transferred to the general ward to continue treatment for 2 days and was discharged after recovery. At 1-month follow-up after discharge, the patient's consciousness was clear, her speech was clear, and the muscle strength of the limbs was back to normal. The cooperation of a mature ECMO team was important in the rescue and treatment of this patient, which could shorten the response time in all aspects of the rescue and improve the success rate of rescue and treatment. The application of individualized therapeutic measures and high-quality nursing care is the key to promote the recovery of this patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.